Investigators used untargeted serum metabolomics to interrogate systemic metabolic changes after a clade C HIV immunization strategy in nine rhesus macaques. The animals received a DNA-prime followed by a protein boost; the abstract lists sampling at baseline (week 0) and at weeks 1, 2 and 8 after the first protein boost. The team reported acute and sustained shifts in circulating metabolites. The source did not include detailed dosing, administration route, or assay platform parameters in the abstract.
Lipid metabolism showed the broadest perturbation after vaccination, the authors reported. Free fatty acids were transiently depleted during the effector phase, implying increased utilization or redistribution shortly after boost. In contrast, several lipid classes remained elevated through week 8: acylcholines, lysophospholipids, and endocannabinoid-like ethanolamides. These persistent elevations suggest a prolonged remodeling of circulating membrane and signalling lipids after the protein boost, the cohort showed. Investigators observed these lipid signatures across the sampled timepoints, but the abstract did not provide absolute concentrations or fold-change values.
Amino acid–linked metabolites also changed and remained altered through week 8. The study team observed increases in glutamate, γ-glutamyl amino acids, and glycylvaline. Data indicated continued nitrogen recycling, elevated glutathione turnover, and heightened proteolytic activity following vaccination. Those findings point to sustained engagement of cellular processes that manage oxidative stress and protein turnover during the post-boost period. The abstract reports these pathway-level observations without presenting specific metabolite lists or quantitative statistics.
The investigators stratified animals by antibody responsiveness and identified serum correlates associated with stronger humoral outcomes. High antibody responders had greater indicators of mitochondrial fatty acid oxidation at baseline and lower bile acid levels before boost. During the effector phase, these animals demonstrated greater membrane lipid remodeling compared with lower responders. The cohort showed this association in the sampled animals, suggesting pre-existing metabolic states and acute lipid dynamics may predict vaccine immunogenicity. The authors described these as serum correlates that merit future testing; the abstract did not report predictive performance metrics or validation in an independent cohort.
The abstract makes clear that an untargeted metabolomics workflow was applied to serum and identifies the regimen (DNA-prime/protein-boost) and sampling windows (weeks 0, 1, 2, 8 after first boost). Beyond that, the source did not report several key technical details in the abstract: exact sample sizes beyond the total of nine animals, the metabolomics platform and instrumentation, metabolite identification criteria, normalization approaches, statistical thresholds, or the precise antibody assays used to define high versus low responders. Those omissions limit reproduction from the abstract alone and will require consulting the full text for laboratory and analytical methods.
The study defines candidate metabolic signatures of HIV vaccination and proposes serum correlates of immunogenicity, the authors noted. The cohort comprised nine rhesus macaques; that small sample size and the absence of independent validation were acknowledged implicitly by the authors’ call for prospective validation. The abstract did not present effect sizes, p-values, or receiver-operating characteristics to quantify how well the metabolic signals discriminate responder status. Prospective studies with pre-specified assays and larger cohorts will be necessary to confirm whether baseline mitochondrial fatty acid oxidation markers, bile acid profiles, or effector-phase lipid remodeling can reliably predict antibody outcomes.
Note: the abstract did not include detailed dosing or administration schedules for the DNA-prime/protein-boost regimen, nor did it report the metabolomics platform, annotation pipeline, or quantitative statistics. For full methodological transparency and reproducibility, readers should consult the full text.